Inactief instrument

Koers Raptor Pharmaceutical Corp

Aandelen

slotkoers Nasdaq Andere beurzen
- ^USD	-

Depomed : Le laboratoire Depomed résigné à se vendre-sources	16-09-16
Exclusive: Drugmaker Depomed prepares to explore a sale - sources	15-09-16
Brower Piven Commences An Investigation Into The Proposed Sale Of Raptor Pharmaceutical Corp. And Encourages Shareholders To Contact The Firm For Additional Information	15-09-16
Raptor Pharmaceutical : Acquisition May Not Be in the Best Interests of RPTP Shareholders	14-09-16
Brower Piven Commences An Investigation Into The Proposed Sale Of Raptor Pharmaceutical Corp. And Encourages Investors To Contact The Firm For Additional Information	12-09-16

Managers	Titel	Leeftijd	Van
Paul Hoelscher DFI	Director of Finance/CFO	59	25-10-16
Kim Lee IRC	Investor Relations Contact	-	23-10-14
Françoise de Craecker PRN	Corporate Officer/Principal	62	-

Besturend	Titel	Leeftijd	Van
Gregg Lapointe CHM	Chairman	65	01-01-15
Timothy Walbert BRD	Director/Board Member	57	11-04-11
Paul Hoelscher DFI	Director of Finance/CFO	59	25-10-16

Sector

	Vaira. 1 jan.	Kapi.
VERTEX PHARMACEUTICALS INCORPORATED	+3,91%	109 mld.
REGENERON PHARMACEUTICALS, INC.	+10,87%	105 mld.
ARGENX SE	+1,28%	22,25 mld.
BIONTECH SE	-13,14%	22,09 mld.
GENMAB A/S	-7,05%	18,68 mld.
WUXI APPTEC CO., LTD.	-38,36%	17,58 mld.
BEIGENE, LTD.	-10,66%	16,85 mld.
NEUROCRINE BIOSCIENCES, INC.	+3,75%	13,76 mld.
SAREPTA THERAPEUTICS, INC.	+36,70%	12,46 mld.